Jacobs Levy Equity Management, Inc Sigilon Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.24 - $3.03 $177,048 - $432,626	-142,781 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.58 - $6.13 $368,374 - $875,247	142,781 New	142,781 $394,000
Q3 2021 Nov 15, 2021	SELL	$4.42 - $10.61 $292,100 - $701,172	-66,086 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.15 - $20.17 $604,686 - $1.33 Million	66,086 New	66,086 $709,000

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.